Junfei Gu

1.2k total citations
42 papers, 879 citations indexed

About

Junfei Gu is a scholar working on Molecular Biology, Cancer Research and Complementary and alternative medicine. According to data from OpenAlex, Junfei Gu has authored 42 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Complementary and alternative medicine. Recurrent topics in Junfei Gu's work include Traditional Chinese Medicine Analysis (6 papers), Natural product bioactivities and synthesis (5 papers) and Cancer-related molecular mechanisms research (4 papers). Junfei Gu is often cited by papers focused on Traditional Chinese Medicine Analysis (6 papers), Natural product bioactivities and synthesis (5 papers) and Cancer-related molecular mechanisms research (4 papers). Junfei Gu collaborates with scholars based in China, United States and Macao. Junfei Gu's co-authors include Shandong Ye, Xiaolu Wang, Xiao‐Bin Jia, Liang Feng, Haitao Gao, Zhan Yang, Changbao Qu, Minghua Zhang, Limin Zhai and Wei Wang and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Junfei Gu

41 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junfei Gu China 19 552 205 103 92 86 42 879
Minglu Liang China 20 441 0.8× 185 0.9× 75 0.7× 128 1.4× 117 1.4× 52 884
Carlos Sànchez‐Martìn Italy 20 607 1.1× 156 0.8× 100 1.0× 109 1.2× 65 0.8× 28 968
Seung‐Nam Jung South Korea 15 426 0.8× 195 1.0× 73 0.7× 80 0.9× 129 1.5× 29 790
Yingdong Lu China 15 462 0.8× 117 0.6× 136 1.3× 59 0.6× 47 0.5× 28 871
Xuguang Hu China 15 379 0.7× 163 0.8× 106 1.0× 78 0.8× 107 1.2× 48 814
Surendar Tadi South Korea 9 456 0.8× 225 1.1× 180 1.7× 82 0.9× 91 1.1× 11 819
Qiao Yang China 19 484 0.9× 131 0.6× 174 1.7× 158 1.7× 136 1.6× 48 1.1k
Qiang Tang China 17 585 1.1× 229 1.1× 112 1.1× 62 0.7× 195 2.3× 44 1.1k
Tao Guo China 17 323 0.6× 186 0.9× 92 0.9× 53 0.6× 60 0.7× 38 782

Countries citing papers authored by Junfei Gu

Since Specialization
Citations

This map shows the geographic impact of Junfei Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfei Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfei Gu more than expected).

Fields of papers citing papers by Junfei Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junfei Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfei Gu. The network helps show where Junfei Gu may publish in the future.

Co-authorship network of co-authors of Junfei Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Junfei Gu. A scholar is included among the top collaborators of Junfei Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junfei Gu. Junfei Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Chao, Jingwei Lv, Yao Chen, et al.. (2025). Machine learning identification of a novel vasculogenic mimicry-related signature and FOXM1’s role in promoting vasculogenic mimicry in clear cell renal cell carcinoma. Translational Oncology. 53. 102312–102312. 2 indexed citations
2.
Wang, Xu, et al.. (2024). Research progress on the effect of pyroptosis on the occurrence, development, invasion and metastasis of colorectal cancer. World Journal of Gastrointestinal Oncology. 16(8). 3410–3427.
3.
Wang, Xu, et al.. (2024). Astragalus mongholicus Bunge and Curcuma aromatica Salisb. modulate gut microbiome and bile acid metabolism to inhibit colon cancer progression. Frontiers in Microbiology. 15. 1395634–1395634. 7 indexed citations
4.
5.
Yang, Zhan, Yaxuan Wang, Jin‐Kun Wen, et al.. (2023). SF3B4 promotes Twist1 expression and clear cell renal cell carcinoma progression by facilitating the export of KLF 16 mRNA from the nucleus to the cytoplasm. Cell Death and Disease. 14(1). 26–26. 15 indexed citations
6.
Zhu, Meng, Ruonan Zhang, Hong Zhang, et al.. (2023). PCGF6/MAX/KDM5D facilitates MAZ/CDK4 axis expression and pRCC progression by hypomethylation of the DNA promoter. Epigenetics & Chromatin. 16(1). 9–9. 3 indexed citations
7.
8.
Zhu, Meng, Bei Shi, Hong Zhang, et al.. (2021). A Novel ZNF304/miR-183-5p/FOXO4 Pathway Regulates Cell Proliferation in Clear Cell Renal Carcinoma. Frontiers in Oncology. 11. 710525–710525. 12 indexed citations
9.
He, Chuan, et al.. (2020). Changes of intestinal microflora of breast cancer in premenopausal women. European Journal of Clinical Microbiology & Infectious Diseases. 40(3). 503–513. 47 indexed citations
10.
Gu, Junfei, Yong Zhang, Zhenwei Han, et al.. (2020). Targeting the ERβ/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC. Cell Death and Disease. 11(5). 367–367. 24 indexed citations
11.
Gao, Lei, Jialin Meng, Yong Zhang, et al.. (2020). Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancer. Genomics. 112(6). 4980–4992. 16 indexed citations
12.
Gu, Junfei, et al.. (2018). Up regulated Tmbim1 activation promotes high fat diet (HFD)-induced cardiomyopathy by enhancement of inflammation and oxidative stress. Biochemical and Biophysical Research Communications. 504(4). 797–804. 10 indexed citations
13.
Xu, Qingyu, Junfei Gu, You Lv, et al.. (2018). Angiogenesis for tumor vascular normalization of Endostar on hepatoma 22 tumor-bearing mice is involved in the immune response. Oncology Letters. 15(3). 3437–3446. 19 indexed citations
14.
Feng, Liang, Maomao Zhu, Junfei Gu, et al.. (2017). Structural composition of components of geoherb Moutan Cortex contributes to anti-diabetic nephropathy activity. Oncotarget. 0(0). 1 indexed citations
15.
Yang, Zhan, Jin‐Kun Wen, Haitao Gao, et al.. (2017). Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel. Journal of Experimental & Clinical Cancer Research. 36(1). 178–178. 77 indexed citations
16.
Zhao, Yanyan, Xuefeng Hou, Feng Guo, et al.. (2017). SIRT1 rs10823108 and FOXO1 rs17446614 responsible for genetic susceptibility to diabetic nephropathy. Scientific Reports. 7(1). 10285–10285. 36 indexed citations
17.
Cheng, Xudong, et al.. (2015). Suppression of A549 cell proliferation and metastasis by calycosin via inhibition of the PKC-α/ERK1/2 pathway: An in vitro investigation. Molecular Medicine Reports. 12(6). 7992–8002. 31 indexed citations
18.
Wang, Chunfei, Junfei Gu, Liang Feng, & Xiao‐Bin Jia. (2015). Development of innovative structural components of Chinese medicine by multidisciplinary crossing. China Journal of Chinese Materia Medica. 40(13). 2496–502. 1 indexed citations
19.
20.
Zhou, Jin‐Yong, Haijun Yu, Xi Zou, et al.. (2014). Hederagenin from the leaves of ivy (Hedera helix L.) induces apoptosis in human LoVo colon cells through the mitochondrial pathway. BMC Complementary and Alternative Medicine. 14(1). 412–412. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minglu Liang Breakdown of academic impact, for papers by Carlos Sànchez‐Martìn Breakdown of academic impact, for papers by Seung‐Nam Jung Breakdown of academic impact, for papers by Yingdong Lu Breakdown of academic impact, for papers by Xuguang Hu Breakdown of academic impact, for papers by Surendar Tadi Breakdown of academic impact, for papers by Qiao Yang Breakdown of academic impact, for papers by Qiang Tang Breakdown of academic impact, for papers by Tao Guo
Rankless by CCL
2026